Neda Laiteerapong to Glucagon-Like Peptide 1
This is a "connection" page, showing publications Neda Laiteerapong has written about Glucagon-Like Peptide 1.
Connection Strength
0.245
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
Score: 0.189
-
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. JAMA Health Forum. 2025 Mar 07; 6(3):e245586.
Score: 0.056